Antihypertensives More Likely than SARS‐CoV‐2 Trigger Parkinson’s Disease
Himalayan Journal of Community Medicine and Public Health · 2020
DOI: 10.47310/hjcmph.2020.v01i01.001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Himalayan Journal of Community Medicine and Public Health, 2020. Verfasst von Josef Finsterer und 1 weiteren Autor:innen.
Abstract (Originalsprache)
We appreciated to read the article by Cohen et al. about a 45yo male suspected of having developed Parkinson’s disease (PD) due to infection with SARS-CoV-2 [1]. It was concluded that SARS-CoV-2 may trigger the development of PD [1]. We have the following comments and concerns.
Zitieren
APA
Finsterer, J., & Scorza, F. (2020). Antihypertensives More Likely than SARS‐CoV‐2 Trigger Parkinson’s Disease. Himalayan Journal of Community Medicine and Public Health. https://doi.org/10.47310/hjcmph.2020.v01i01.001
Vancouver
Finsterer J, Scorza F. Antihypertensives More Likely than SARS‐CoV‐2 Trigger Parkinson’s Disease. Himalayan Journal of Community Medicine and Public Health. 2020. doi:10.47310/hjcmph.2020.v01i01.001
BibTeX
@article{Finsterer2020,
author = {Finsterer, Josef and Scorza, F.A.},
title = {Antihypertensives More Likely than SARS‐CoV‐2 Trigger Parkinson’s Disease},
journal = {Himalayan Journal of Community Medicine and Public Health},
year = {2020},
doi = {10.47310/hjcmph.2020.v01i01.001}
}
EUVIMED